Affilogic
Maurine Fleury is an experienced bio-production manager at Affilogic since December 2019, with prior experience as a trainee engineer in neuro-oncology at GlioCure, where research focused on peptide formulation and anti-tumor activity. Additional experience includes a trainee position in cardiovascular genetics at l'institut du thorax, working on methods for analyzing the human cardiac regulome in relation to specific heart syndromes, and developing a 3D in vitro model of the blood-brain barrier during a traineeship at The Open University. Maurine Fleury holds a Master's degree in Biotechnology from ENSTBB Bordeaux INP and a Licence in Life Sciences with a focus on Biotechnology from ICES - Institut catholique de Vendée.
This person is not in any teams
Affilogic
Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, including a wide range of circulating antigens (peptides, proteins), membrane receptors for inhibition / modulation (GPCR, ion channels) and complex entities (virus-like particles, bacteria, whole cells).